Showing results (131-140 of 2,878) with videos related to
Sort By:
Pageof 288
Journal of Neurology|November 7, 1999
Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patientsM Mäurer, N Kruse, R Giess, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1991
Analysis of cis-acting elements present in the CD20/B1 antigen promoterP Rieckmann, G L Wilson, C Thevenin, et al.Journal of Neurology|August 1, 1996
Fasciculations: clinical, electromyographic, and ultrasonographic assessmentC D Reimers, U Ziemann, A Scheel, et al.Clinical and Experimental Immunology|March 1, 1997
Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitisG Zysk, W Brück, F R Fischer, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell functionP Rieckmann, F D'Alessandro, R P Nordan, et al.Journal of Neurology|March 1, 1995
A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseasesM Puccioni-Sohler, P Rieckmann, B Kitze, et al.Acta Neuropathologica|April 29, 1998
Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosisA Bitsch, C da Costa, S Bunkowski, et al.Der Nervenarzt|April 20, 2010
[Amyotrophic lateral sclerosis: management of bulbar symptoms]P Kraft, M Beck, A Grimm, et al.Der Nervenarzt|November 12, 2015
["Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy]R Linker, B-A Kallmann, C Kleinschnitz, et al.Der Nervenarzt|September 15, 2005
["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]P Flachenecker, G Müller, H König, et al.Pageof 288